These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 22515289)
1. Nuclear expression of S-phase kinase-associated protein 2 predicts poor prognosis of hepatocellular carcinoma. Shin E; Kim SH; Jeong HY; Jang JJ; Lee K APMIS; 2012 May; 120(5):349-57. PubMed ID: 22515289 [TBL] [Abstract][Full Text] [Related]
2. Clinicopathologic significance and function of S-phase kinase-associated protein 2 overexpression in hepatocellular carcinoma. Zhang SH; Qian YM; Liu AW; Cai J; Zhao XL; Wei JJ; Zhu MH Hum Pathol; 2012 Jul; 43(7):1084-93. PubMed ID: 22204716 [TBL] [Abstract][Full Text] [Related]
3. CKS1B overexpression implicates clinical aggressiveness of hepatocellular carcinomas but not p27(Kip1) protein turnover: an independent prognosticator with potential p27 (Kip1)-independent oncogenic attributes? Huang CW; Lin CY; Huang HY; Liu HW; Chen YJ; Shih DF; Chen HY; Juan CC; Ker CG; Huang CY; Li CF; Shiue YL Ann Surg Oncol; 2010 Mar; 17(3):907-22. PubMed ID: 19866239 [TBL] [Abstract][Full Text] [Related]
4. Prognostic implication of p27Kip1, Skp2 and Cks1 expression in renal cell carcinoma: a tissue microarray study. Liu Z; Fu Q; Lv J; Wang F; Ding K J Exp Clin Cancer Res; 2008 Oct; 27(1):51. PubMed ID: 18922157 [TBL] [Abstract][Full Text] [Related]
5. Immunohistochemically detected expression of p27(Kip1) and Skp2 predicts survival in patients with intrahepatic cholangiocarcinomas. Hashimoto N; Yachida S; Okano K; Wakabayashi H; Imaida K; Kurokohchi K; Masaki T; Kinoshita H; Tominaga M; Ajiki T; Ku Y; Okabayashi T; Hanazaki K; Hiroi M; Izumi S; Mano S; Okada S; Karasawa Y; Maeba T; Suzuki Y Ann Surg Oncol; 2009 Feb; 16(2):395-403. PubMed ID: 19034576 [TBL] [Abstract][Full Text] [Related]
6. Skp2 overexpression is highly representative of intrinsic biological aggressiveness and independently associated with poor prognosis in primary localized myxofibrosarcomas. Huang HY; Kang HY; Li CF; Eng HL; Chou SC; Lin CN; Hsiung CY Clin Cancer Res; 2006 Jan; 12(2):487-98. PubMed ID: 16428491 [TBL] [Abstract][Full Text] [Related]
7. High expression of S-phase kinase-interacting protein 2, human F-box protein, correlates with poor prognosis in oral squamous cell carcinomas. Kudo Y; Kitajima S; Sato S; Miyauchi M; Ogawa I; Takata T Cancer Res; 2001 Oct; 61(19):7044-7. PubMed ID: 11585732 [TBL] [Abstract][Full Text] [Related]
8. Early mitotic inhibitor-1, an anaphase-promoting complex/cyclosome inhibitor, can control tumor cell proliferation in hepatocellular carcinoma: correlation with Skp2 stability and degradation of p27(Kip1). Zhao Y; Tang Q; Ni R; Huang X; Wang Y; Lu C; Shen A; Wang Y; Li C; Yuan Q; Chen H; Cheng C; He S Hum Pathol; 2013 Mar; 44(3):365-73. PubMed ID: 22995332 [TBL] [Abstract][Full Text] [Related]
9. Expression of p27 and its ubiquitin ligase subunit Skp2 in upper urinary tract transitional cell carcinoma. Langner C; von Wasielewski R; Ratschek M; Rehak P; Zigeuner R Urology; 2004 Sep; 64(3):611-6. PubMed ID: 15351619 [TBL] [Abstract][Full Text] [Related]
10. Regulation of p27 by S-phase kinase-associated protein 2 is associated with aggressiveness in non-small-cell lung cancer. Osoegawa A; Yoshino I; Tanaka S; Sugio K; Kameyama T; Yamaguchi M; Maehara Y J Clin Oncol; 2004 Oct; 22(20):4165-73. PubMed ID: 15483027 [TBL] [Abstract][Full Text] [Related]
11. Alterations in the expression of the cell cycle regulatory protein cyclin kinase subunit 1 in colorectal carcinoma. Shapira M; Ben-Izhak O; Bishara B; Futerman B; Minkov I; Krausz MM; Pagano M; Hershko DD Cancer; 2004 Apr; 100(8):1615-21. PubMed ID: 15073847 [TBL] [Abstract][Full Text] [Related]
12. S-phase kinase-associated protein 2 expression in laryngeal squamous cell carcinomas and its prognostic implications. Dong Y; Sui L; Watanabe Y; Sugimoto K; Tokuda M Oncol Rep; 2003; 10(2):321-5. PubMed ID: 12579266 [TBL] [Abstract][Full Text] [Related]
13. Increased SKP2 and CKS1 gene expression contributes to the progression of human urothelial carcinoma. Kawakami K; Enokida H; Tachiwada T; Nishiyama K; Seki N; Nakagawa M J Urol; 2007 Jul; 178(1):301-7. PubMed ID: 17499794 [TBL] [Abstract][Full Text] [Related]
14. The combination of high cyclin E and Skp2 expression in breast cancer is associated with a poor prognosis and the basal phenotype. Voduc D; Nielsen TO; Cheang MC; Foulkes WD Hum Pathol; 2008 Oct; 39(10):1431-7. PubMed ID: 18620730 [TBL] [Abstract][Full Text] [Related]
15. Skp2 and p27kip1 expression in melanocytic nevi and melanoma: an inverse relationship. Li Q; Murphy M; Ross J; Sheehan C; Carlson JA J Cutan Pathol; 2004 Nov; 31(10):633-42. PubMed ID: 15491322 [TBL] [Abstract][Full Text] [Related]
16. Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence. Ito Y; Matsuura N; Sakon M; Miyoshi E; Noda K; Takeda T; Umeshita K; Nagano H; Nakamori S; Dono K; Tsujimoto M; Nakahara M; Nakao K; Taniguchi N; Monden M Hepatology; 1999 Jul; 30(1):90-9. PubMed ID: 10385644 [TBL] [Abstract][Full Text] [Related]
17. Clinical and biological significance of S-phase kinase-associated protein 2 (Skp2) gene expression in gastric carcinoma: modulation of malignant phenotype by Skp2 overexpression, possibly via p27 proteolysis. Masuda TA; Inoue H; Sonoda H; Mine S; Yoshikawa Y; Nakayama K; Nakayama K; Mori M Cancer Res; 2002 Jul; 62(13):3819-25. PubMed ID: 12097295 [TBL] [Abstract][Full Text] [Related]
18. Significance of skp2 expression in primary breast cancer. Sonoda H; Inoue H; Ogawa K; Utsunomiya T; Masuda TA; Mori M Clin Cancer Res; 2006 Feb; 12(4):1215-20. PubMed ID: 16489076 [TBL] [Abstract][Full Text] [Related]
19. Clinical significance of Skp2 expression, alone and combined with Jab1 and p27 in epithelial ovarian tumors. Sui L; Dong Y; Watanabe Y; Yamaguchi F; Sugimoto K; Tokuda M Oncol Rep; 2006 Apr; 15(4):765-71. PubMed ID: 16525656 [TBL] [Abstract][Full Text] [Related]
20. COX-2 correlates with F-box protein, Skp2 expression and prognosis in human gastric carcinoma. Honjo S; Kase S; Osaki M; Ardyanto TD; Kaibara N; Ito H Int J Oncol; 2005 Feb; 26(2):353-60. PubMed ID: 15645119 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]